CLARANOVA SE (CLA.PA) Fundamental Analysis & Valuation

EPA:CLA • FR0013426004

Current stock price

1.07 EUR
+0.02 (+1.9%)
Last:

This CLA.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CLA.PA Profitability Analysis

1.1 Basic Checks

  • CLA had positive earnings in the past year.
  • In the past year CLA had a positive cash flow from operations.
  • In multiple years CLA reported negative net income over the last 5 years.
  • CLA had a positive operating cash flow in each of the past 5 years.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 54.15%, CLA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • CLA's Return On Equity of 179.32% is amongst the best of the industry. CLA outperforms 99.15% of its industry peers.
  • With an excellent Return On Invested Capital value of 16.07%, CLA belongs to the best of the industry, outperforming 86.32% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CLA is above the industry average of 13.30%.
Industry RankSector Rank
ROA 54.15%
ROE 179.32%
ROIC 16.07%
ROA(3y)15.08%
ROA(5y)9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.83%
ROIC(5y)14.14%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

  • The Profit Margin of CLA (25.09%) is better than 82.91% of its industry peers.
  • In the last couple of years the Profit Margin of CLA has grown nicely.
  • With a Operating Margin value of 6.64%, CLA perfoms like the industry average, outperforming 56.41% of the companies in the same industry.
  • CLA's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 80.16%, CLA is doing good in the industry, outperforming 68.38% of the companies in the same industry.
  • CLA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.64%
PM (TTM) 25.09%
GM 80.16%
OM growth 3Y58.64%
OM growth 5Y43.87%
PM growth 3YN/A
PM growth 5Y248.09%
GM growth 3Y26.81%
GM growth 5Y17.73%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CLA.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLA is creating value.
  • The number of shares outstanding for CLA has been increased compared to 1 year ago.
  • Compared to 5 years ago, CLA has more shares outstanding
  • The debt/assets ratio for CLA has been reduced compared to a year ago.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • CLA has an Altman-Z score of 1.15. This is a bad value and indicates that CLA is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.15, CLA is not doing good in the industry: 67.52% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of CLA is 2.40, which is a good value as it means it would take CLA, 2.40 years of fcf income to pay off all of its debts.
  • CLA has a Debt to FCF ratio of 2.40. This is comparable to the rest of the industry: CLA outperforms 54.70% of its industry peers.
  • CLA has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
  • CLA's Debt to Equity ratio of 1.10 is on the low side compared to the rest of the industry. CLA is outperformed by 82.05% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for CLA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 2.4
Altman-Z 1.15
ROIC/WACC2.01
WACC7.98%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.83 indicates that CLA may have some problems paying its short term obligations.
  • CLA's Current ratio of 0.83 is on the low side compared to the rest of the industry. CLA is outperformed by 83.76% of its industry peers.
  • A Quick Ratio of 0.80 indicates that CLA may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.80, CLA is not doing good in the industry: 86.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.8
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CLA.PA Growth Analysis

3.1 Past

  • CLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 706.69%, which is quite impressive.
  • CLA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 152.38% yearly.
  • Looking at the last year, CLA shows a decrease in Revenue. The Revenue has decreased by -2.36% in the last year.
  • CLA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -22.02% yearly.
EPS 1Y (TTM)706.69%
EPS 3YN/A
EPS 5Y152.38%
EPS Q2Q%566.67%
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-37.08%
Revenue growth 5Y-22.02%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.92% on average over the next years.
  • CLA is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -37.74% yearly.
EPS Next Y-46.15%
EPS Next 2Y-3.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-63.38%
Revenue Next 2Y-37.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

More info and screens

Find the best growth stocksShow best growing peers

8

4. CLA.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 0.83, the valuation of CLA can be described as very cheap.
  • Based on the Price/Earnings ratio, CLA is valued cheaper than 100.00% of the companies in the same industry.
  • CLA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.61.
  • Based on the Price/Forward Earnings ratio of 7.57, the valuation of CLA can be described as very cheap.
  • 94.87% of the companies in the same industry are more expensive than CLA, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CLA to the average of the S&P500 Index (22.79), we can say CLA is valued rather cheaply.
Industry RankSector Rank
PE 0.83
Fwd PE 7.57
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLA is valued cheaply inside the industry as 98.29% of the companies are valued more expensively.
  • CLA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CLA is cheaper than 99.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.96
EV/EBITDA 3.21
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • The excellent profitability rating of CLA may justify a higher PE ratio.
  • CLA's earnings are expected to decrease with -3.92% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2Y-3.92%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLA.PA Dividend Analysis

5.1 Amount

  • No dividends for CLA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLA.PA Fundamentals: All Metrics, Ratios and Statistics

CLARANOVA SE

EPA:CLA (2/10/2026, 7:00:00 PM)

1.07

+0.02 (+1.9%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-11
Earnings (Next)05-21
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap61.21M
Revenue(TTM)293.80M
Net Income(TTM)73.70M
Analysts80
Price Target2.45 (128.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-28.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.53%
Valuation
Industry RankSector Rank
PE 0.83
Fwd PE 7.57
P/S 0.21
P/FCF 2.96
P/OCF 2.6
P/B 1.49
P/tB N/A
EV/EBITDA 3.21
EPS(TTM)1.29
EY120.56%
EPS(NY)0.14
Fwd EY13.21%
FCF(TTM)0.36
FCFY33.82%
OCF(TTM)0.41
OCFY38.39%
SpS5.14
BVpS0.72
TBVpS-0.88
PEG (NY)N/A
PEG (5Y)0.01
Graham Number4.57
Profitability
Industry RankSector Rank
ROA 54.15%
ROE 179.32%
ROCE 21.86%
ROIC 16.07%
ROICexc 20.86%
ROICexgc N/A
OM 6.64%
PM (TTM) 25.09%
GM 80.16%
FCFM 7.05%
ROA(3y)15.08%
ROA(5y)9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.83%
ROIC(5y)14.14%
ROICexc(3y)41.64%
ROICexc(5y)35.57%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)22.9%
ROCE(5y)19.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-2.71%
ROICexc growth 5Y6.36%
OM growth 3Y58.64%
OM growth 5Y43.87%
PM growth 3YN/A
PM growth 5Y248.09%
GM growth 3Y26.81%
GM growth 5Y17.73%
F-Score8
Asset Turnover2.16
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 2.4
Debt/EBITDA 1.93
Cap/Depr 70%
Cap/Sales 0.95%
Interest Coverage 250
Cash Conversion 100%
Profit Quality 28.09%
Current Ratio 0.83
Quick Ratio 0.8
Altman-Z 1.15
F-Score8
WACC7.98%
ROIC/WACC2.01
Cap/Depr(3y)69.81%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)706.69%
EPS 3YN/A
EPS 5Y152.38%
EPS Q2Q%566.67%
EPS Next Y-46.15%
EPS Next 2Y-3.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-37.08%
Revenue growth 5Y-22.02%
Sales Q2Q%N/A
Revenue Next Year-63.38%
Revenue Next 2Y-37.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.72%
EBIT growth 3Y-0.17%
EBIT growth 5Y12.2%
EBIT Next Year-17.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40%
FCF growth 3Y14.47%
FCF growth 5Y-6.06%
OCF growth 1Y-40.81%
OCF growth 3Y13.67%
OCF growth 5Y-4.45%

CLARANOVA SE / CLA.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CLARANOVA SE?

ChartMill assigns a fundamental rating of 4 / 10 to CLA.PA.


Can you provide the valuation status for CLARANOVA SE?

ChartMill assigns a valuation rating of 8 / 10 to CLARANOVA SE (CLA.PA). This can be considered as Undervalued.


How profitable is CLARANOVA SE (CLA.PA) stock?

CLARANOVA SE (CLA.PA) has a profitability rating of 8 / 10.


What is the financial health of CLARANOVA SE (CLA.PA) stock?

The financial health rating of CLARANOVA SE (CLA.PA) is 2 / 10.


Can you provide the expected EPS growth for CLA stock?

The Earnings per Share (EPS) of CLARANOVA SE (CLA.PA) is expected to decline by -46.15% in the next year.